BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND FH, HLRCC, 2271, ENSG00000091483, MCUL1, MCL, LRCC, P07954
495 results:

  • 1. Effective Targeting of Melanoma cells by Combination of mcl-1 and Bcl-2/Bcl-x
    Peng Z; Gillissen B; Richter A; Sinnberg T; Schlaak MS; Eberle J
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542429
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. tumor Treating Fields (TTFields) combined with the drug repurposing approach CUSP9v3 induce metabolic reprogramming and synergistic anti-glioblastoma activity in vitro.
    Cao Q; Hajosch A; Kast RE; Loehmann C; Hlavac M; Fischer-Posovszky P; Strobel H; Westhoff MA; Siegelin MD; Wirtz CR; Halatsch ME; Karpel-Massler G
    Br J Cancer; 2024 May; 130(8):1365-1376. PubMed ID: 38396172
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical trials of R-(-)-gossypol (AT-101) in newly diagnosed and recurrent glioblastoma: NABTT 0602 and NABTT 0702.
    Fiveash JB; Ye X; Peerboom DM; Mikkelsen T; Chowdhary S; Rosenfeld M; Lesser GJ; Fisher J; Desideri S; Grossman S; Leopold L; Nabors LB
    PLoS One; 2024; 19(1):e0291128. PubMed ID: 38285688
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trial.
    Le Rhun E; Gorlia T; Felsberg J; Jongen J; Maurage CA; Ducray F; Gramatzki D; Hau P; Chinot OL; Preusser M; Cartalat S; Roth P; van den Bent M; Furtner J; Collienne M; Reifenberger G; Weller M
    Eur J Cancer; 2024 Feb; 198():113475. PubMed ID: 38159337
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Update on Selected High-grade Renal cell Carcinomas of the Kidney: FH-deficient, ALK-rearranged, and Medullary Carcinomas.
    Chen YB
    Adv Anat Pathol; 2024 Mar; 31(2):118-125. PubMed ID: 38145398
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The identification of BCL-XL and mcl-1 as key anti-apoptotic proteins in medulloblastoma that mediate distinct roles in chemotherapy resistance.
    Fitzgerald MC; O'Halloran PJ; Kerrane SA; Ní Chonghaile T; Connolly NMC; Murphy BM
    Cell Death Dis; 2023 Oct; 14(10):705. PubMed ID: 37898609
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The connection between tricarboxylic acid cycle enzyme mutations and pseudohypoxic signaling in pheochromocytoma and paraganglioma.
    Wang Y; Liu B; Li F; Zhang Y; Gao X; Wang Y; Zhou H
    Front Endocrinol (Lausanne); 2023; 14():1274239. PubMed ID: 37867526
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Combined mcl-1 and YAP1/TAZ inhibition for treatment of metastatic uveal melanoma.
    Glinkina KA; Teunisse AFAS; Gelmi MC; de Vries J; Jager MJ; Jochemsen AG
    Melanoma Res; 2023 Oct; 33(5):345-356. PubMed ID: 37467061
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Bcl-2 family inhibitors sensitize human cancer models to therapy.
    Valentini E; Di Martile M; Brignone M; Di Caprio M; Manni I; Chiappa M; Sergio I; Chiacchiarini M; Bazzichetto C; Conciatori F; D'Aguanno S; D'Angelo C; Ragno R; Russillo M; Colotti G; Marchesi F; Bellone ML; Dal Piaz F; Felli MP; Damia G; Del Bufalo D
    Cell Death Dis; 2023 Jul; 14(7):441. PubMed ID: 37460459
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. CAFs targeted ultrasound-responsive nanodroplets loaded V9302 and GLULsiRNA to inhibit melanoma growth via glutamine metabolic reprogramming and tumor microenvironment remodeling.
    Ai C; Sun X; Xiao S; Guo L; Shang M; Shi D; Meng D; Zhao Y; Wang X; Li J
    J Nanobiotechnology; 2023 Jul; 21(1):214. PubMed ID: 37420266
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The Effect of 5-aza,2'-deoxyCytidine (5 AZA CdR or Decitabine) on Extrinsic, Intrinsic, and JAK/STAT Pathways in Neuroblastoma and Glioblastoma cells Lines.
    Sanaei M; Kavoosi F
    Asian Pac J Cancer Prev; 2023 Jun; 24(6):1841-1854. PubMed ID: 37378911
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Advanced fumarate hydratase-deficient renal cell carcinoma responding to combination immune checkpoint inhibitors.
    Howells E; Wigston L; Mackie G; Tran B; Nott L
    Can J Urol; 2023 Jun; 30(3):11558-11561. PubMed ID: 37344468
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Fumarate Hydratase-Deficient Leiomyoma of the Uterine Corpus: Comparative Morphologic Analysis of Protein-Deficient tumors With and Without Pathogenic germline Fumarate Hydratase Gene Mutations.
    Shi W; Liu Y; Aisagbonhi O; Roma AA; Hasteh F; Zare SY; Fadare O
    Int J Surg Pathol; 2024 Apr; 32(2):340-355. PubMed ID: 37312573
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Fumarate hydratase deficient uterine leiomyoma: a clinicopathological and molecular analysis of 80 cases].
    Wang XX; Liu Y; Liu LC; Wang YX; Yang J; Hu AJ; Zhang B; Liu CR
    Zhonghua Bing Li Xue Za Zhi; 2023 Jun; 52(6):574-579. PubMed ID: 37263921
    [No Abstract]    [Full Text] [Related]  

  • 15. Ponicidin Induces Apoptosis of Murine Melanoma by Inhibiting the NF-κB Signaling Pathway.
    Wang L; Lou X; Wang D; Lu K; Zhang S; Cheng B
    Biol Pharm Bull; 2023; 46(6):803-810. PubMed ID: 37258145
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Diseases of Hereditary Renal cell Cancers.
    Iliopoulos O
    Urol Clin North Am; 2023 May; 50(2):205-215. PubMed ID: 36948667
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Enhanced Apoptosis and Loss of cell Viability in Melanoma cells by Combined Inhibition of ERK and mcl-1 Is Related to Loss of Mitochondrial Membrane Potential, Caspase Activation and Upregulation of Proapoptotic Bcl-2 Proteins.
    Peng Z; Gillissen B; Richter A; Sinnberg T; Schlaak MS; Eberle J
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902392
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Metabolomics in paraganglioma: applications and perspectives from genetics to therapy.
    Richter S; Garrett TJ; Bechmann N; Clifton-Bligh RJ; Ghayee HK
    Endocr Relat Cancer; 2023 Jun; 30(6):. PubMed ID: 36897220
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Fumarate Hydratase Variants and Their Association With Paraganglioma/Pheochromocytoma.
    Zavoshi S; Lu E; Boutros PC; Zhang L; Harari A; Hatchell KE; Nielsen SM; Esplin ED; Ouyang K; Nykamp K; Wilde B; Christofk H; Shuch B
    Urology; 2023 Jun; 176():106-114. PubMed ID: 36773955
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Survival Mechanisms of Metastatic Melanoma cells: The Link between Glucocorticoids and the Nrf2-Dependent Antioxidant Defense System.
    Obrador E; Salvador-Palmer R; López-Blanch R; Oriol-Caballo M; Moreno-Murciano P; Estrela JM
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766760
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 25.